Analysis of newly identified adhesin used by pathogenic Gram-negative bacteria
致病性革兰氏阴性菌使用的新发现的粘附素的分析
基本信息
- 批准号:8304009
- 负责人:
- 金额:$ 19.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-08-01 至 2014-07-31
- 项目状态:已结题
- 来源:
- 关键词:ActinsAdhesionsAnimalsAttenuatedBacteriaBacterial AdhesinsBacterial InfectionsBacterial TypingBindingBiochemicalBiologicalCell Adhesion MoleculesCell-Matrix JunctionCellsConsumptionCytoskeletonFibronectin ReceptorsFibronectinsFoundationsFutureGastroenteritisGenesGoalsGram-Negative BacteriaHemolysinInfectionInvestigationLeadLipidsMediatingMembrane ProteinsPhosphatidic AcidProductionProteinsReceptor CellRecombinantsRoleSeafoodSignal PathwaySignal TransductionStagingSurfaceType III Secretion System PathwayVibrio parahaemolyticuscytotoxicityinhibitor/antagonistinsightinterestnovelpathogenprotein protein interactionreceptorresearch study
项目摘要
DESCRIPTION (provided by applicant): The aim of this proposal is to characterize a newly multivalent adhesion molecule (MAM7) found in the majority of Gram-negative pathogenic animal bacteria. We propose that MAM7 is involved in the initial contact of bacterial pathogens with host cells. As a representative for this type of molecule, we will use the MAM7 protein from Vibrio parahaemolyticus, an emerging pathogen that causes gastroenteritis through consumption of raw or undercooked seafood, to study the multivalent binding to host cells. We observe MAM7 dependent changes in the actin cytoskeleton in host cells. We predict that binding of MAM7 will trigger the production of more adhesion factors in the bacterial pathogens. Thus as one of our aims, we would like to uncover the signaling machinery activated in the bacteria and the host cell upon binding of MAM7. In another aim, we would like to understand the biochemical interaction of MAM7 with its two host cell receptors, fibronectin and phosphatidic acid. This information will be extremely valuable for future studies focused on MAM7 inhibitors. Finally, we observe that binding of non-pathogenic bacteria expressing MAM7 (BL21-MAM7) to host cells ameliorates cytotoxicity of Gram-negative pathogens expressing MAM7. We are interested in determining how broadly MAM7 provides a competitive advantage over other types of bacterial pathogens that do not express MAM7 but other types of adhesins. Together, these experiments will allow us to characterize the newly identified multivalent adhesion molecule MAM7 and will help to elucidate its value as a competitive inhibitor for a wide variety of bacterial pathogens.
PUBLIC HEALTH RELEVANCE: The aim of this proposal is to characterize a newly identified multivalent adhesion molecule (MAM7) that mediates the initial interaction between the eukaryotic host and the bacterial pathogen. We will use the MAM7 from Vibrio parahaemolyticus, an emerging pathogen that causes gastroenteritis through consumption of raw or undercooked sea food, to study the host/pathogen crosstalk upon binding of MAM7 to the previously identified host cell receptors, determine the biochemical interaction of host receptors with MAM7 and elucidate the value of MAM7 in augmenting bacterial infections.
描述(由申请人提供):本提案旨在表征在大多数革兰氏阴性致病动物细菌中发现的新多价粘附分子(MAM 7)。我们认为MAM 7参与了细菌病原体与宿主细胞的初始接触。作为这类分子的代表,我们将使用来自副溶血性弧菌的MAM 7蛋白,这是一种通过食用生的或未煮熟的海鲜引起胃肠炎的新兴病原体,以研究与宿主细胞的多价结合。我们观察到MAM 7依赖的变化,在宿主细胞中的肌动蛋白细胞骨架。我们预测MAM 7的结合将触发细菌病原体中更多粘附因子的产生。因此,作为我们的目标之一,我们希望揭示MAM 7结合后细菌和宿主细胞中激活的信号机制。在另一个目标中,我们想了解MAM 7与其两种宿主细胞受体纤连蛋白和磷脂酸的生物化学相互作用。这一信息将是非常有价值的未来研究重点MAM 7抑制剂。最后,我们观察到表达MAM 7的非致病性细菌(BL 21-MAM 7)与宿主细胞的结合改善了表达MAM 7的革兰氏阴性病原体的细胞毒性。我们感兴趣的是确定MAM 7在多大程度上提供了比不表达MAM 7但表达其他类型粘附素的其他类型细菌病原体的竞争优势。总之,这些实验将使我们能够表征新鉴定的多价粘附分子MAM 7,并将有助于阐明其作为多种细菌病原体的竞争性抑制剂的价值。
公共卫生相关性:本提案的目的是表征一种新鉴定的多价粘附分子(MAM 7),其介导真核宿主与细菌病原体之间的初始相互作用。我们将使用MAM 7从副溶血性弧菌,一种新兴的病原体,导致胃肠炎,通过消费生的或未煮熟的海产品,研究宿主/病原体串扰后,MAM 7的结合到先前确定的宿主细胞受体,确定与MAM 7的宿主受体的生物化学相互作用,并阐明MAM 7在增加细菌感染的价值。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kim Orth其他文献
Kim Orth的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kim Orth', 18)}}的其他基金
FASEB's The Microbial Pathogenesis Conference: Mechanisms of Infectious Disease
FASEB 微生物发病机制会议:传染病机制
- 批准号:
10228853 - 财政年份:2021
- 资助金额:
$ 19.87万 - 项目类别:
Biochemistry, biology and diversity of Fic domains
生物化学、生物学和 Fic 领域的多样性
- 批准号:
10550154 - 财政年份:2020
- 资助金额:
$ 19.87万 - 项目类别:
Biochemistry, biology and diversity of Fic domains
生物化学、生物学和 Fic 领域的多样性
- 批准号:
10334464 - 财政年份:2020
- 资助金额:
$ 19.87万 - 项目类别:
Biochemistry, biology and diversity of Fic domains
生物化学、生物学和 Fic 领域的多样性
- 批准号:
10092197 - 财政年份:2020
- 资助金额:
$ 19.87万 - 项目类别:
Proteostasis, AMPylation and the Unfolded Protein repsonse (UPR)
蛋白质稳态、AMPylation 和未折叠蛋白反应 (UPR)
- 批准号:
9229559 - 财政年份:2015
- 资助金额:
$ 19.87万 - 项目类别:
Proteostasis, AMPylation and the Unfolded Protein repsonse (UPR)
蛋白质稳态、AMPylation 和未折叠蛋白反应 (UPR)
- 批准号:
8914100 - 财政年份:2015
- 资助金额:
$ 19.87万 - 项目类别:
Analysis of newly identified adhesin used by pathogenic Gram-negative bacteria
致病性革兰氏阴性菌使用的新发现的粘附素的分析
- 批准号:
8518227 - 财政年份:2012
- 资助金额:
$ 19.87万 - 项目类别:
Analysis of an orchestrated cell death mediated by Vibrio parahaemolytics T3SS1
副溶血弧菌 T3SS1 介导的精心策划的细胞死亡分析
- 批准号:
8431443 - 财政年份:2010
- 资助金额:
$ 19.87万 - 项目类别:
Analysis of an orchestrated cell death mediated by Vibrio parahaemolytics T3SS1
副溶血弧菌 T3SS1 介导的精心策划的细胞死亡分析
- 批准号:
7867642 - 财政年份:2010
- 资助金额:
$ 19.87万 - 项目类别:
Analysis of an orchestrated cell death mediated by Vibrio parahaemolytics T3SS1
副溶血弧菌 T3SS1 介导的精心策划的细胞死亡分析
- 批准号:
8225260 - 财政年份:2010
- 资助金额:
$ 19.87万 - 项目类别:
相似海外基金
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y004841/1 - 财政年份:2024
- 资助金额:
$ 19.87万 - 项目类别:
Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
- 批准号:
BB/Y001427/1 - 财政年份:2024
- 资助金额:
$ 19.87万 - 项目类别:
Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y005414/1 - 财政年份:2024
- 资助金额:
$ 19.87万 - 项目类别:
Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
- 批准号:
10669829 - 财政年份:2023
- 资助金额:
$ 19.87万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10587090 - 财政年份:2023
- 资助金额:
$ 19.87万 - 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
- 批准号:
10821599 - 财政年份:2023
- 资助金额:
$ 19.87万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10841832 - 财政年份:2023
- 资助金额:
$ 19.87万 - 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
- 批准号:
10532480 - 财政年份:2022
- 资助金额:
$ 19.87万 - 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
- 批准号:
10741261 - 财政年份:2022
- 资助金额:
$ 19.87万 - 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
- 批准号:
10674894 - 财政年份:2022
- 资助金额:
$ 19.87万 - 项目类别: